Table 1.
Number of patients | Proportion (%) | |
---|---|---|
Total | 14,260 | – |
Age | 63.5 ± 13.2a | – |
Sex | ||
Male | 12,022 | 84.3 |
Female | 2238 | 15.7 |
BMI | 23.1 ± 3.2a | – |
Onset | ||
Primary | 12,037 | 84.4 |
Recurrent | 2223 | 15.6 |
Histology | ||
Urothelial carcinoma | 13,037 | 91.4 |
Squamous carcinoma | 274 | 1.9 |
Adenocarcinoma | 261 | 1.8 |
Others | 688 | 4.9 |
Grade, 1973 WHO | 8673 | |
Grade 1 | 3627 | 42.0 |
Grade 2 | 3546 | 41.0 |
Grand 3 | 1466 | 17.0 |
Grade, 2004 WHO | 10,893 | |
PUNLMP | 1732 | 16.0 |
Low-grade | 5276 | 48.7 |
High-grade | 3831 | 35.3 |
T classification | ||
Ta | 4667 | 32.7 |
Primary CIS | 108 | 0.8 |
T1 | 5786 | 40.6 |
T2 or higher | 3591 | 25.2 |
Unclear | 108 | 0.8 |
Concurrent CIS | 223 | 1.6 |
BMI, body mass index; PUNLMP, papillary urothelial neoplasm of low malignant potential; CIS, carcinoma in situ.
Mean ± SD.